Tela Bio Inc (TELA) Stock Price, Quote & News

Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex...

Industry: Medical Devices

Sector: Healthcare

Phone: 484 320 2930

Website: www.telabio.com

Address:

1 Great Valley Parkway, Suite 24, Malvern, United States

EarningsInsider May. 12 at 10:08 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-tela-bio-inc-stock/ $TELA TELA Bio Earnings Transcript

0 · Reply

StocktwitsEarnings May. 12 at 8:16 PM

$TELA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.21 up 16.00% YoY • Reported revenue of $19.06M up 2.91% YoY • TELA Bio reiterated full year 2026 revenue growth guidance of at least 8% over full year 2025 and expects second quarter 2026 revenue to be approximately $20M.

0 · Reply

Dr_Monkeybreath May. 6 at 4:11 PM

$TELA back under .70 please. 🥺

0 · Reply

StockScanners May. 5 at 5:32 AM

$TELA reached 1.17

0 · Reply

InvestingSpaceman May. 4 at 8:00 PM

$TELA $CUE $XRX $ESPR 5 day

0 · Reply

ja1234567 May. 4 at 7:10 PM

$TELA I agree with mimedx maybe buying them. Mimedx is moving more into surgical where Telabio lives. This would make them a portfolio surgical company.

0 · Reply

rombrento May. 4 at 6:28 PM

$TELA

0 · Reply

GlobalInsights May. 4 at 5:58 PM

$TELA Took an opening position of 10k shares today. Their new sales force strategy seems to have potential for accelerating growth. Plus seems like a potential buy out target by MDXG.

0 · Reply

Dr_Monkeybreath May. 4 at 1:58 PM

$TELA still hold some free ones. this could spike above $1. 😶‍🌫️

0 · Reply

StockScanners May. 2 at 4:05 PM

$TELA keep watch if this holds above .82

0 · Reply

TELA Bio Earnings Call Transcript: Q1 2026

May 12, 2026, 4:05 PM EDT - 16 hours ago

TELA Bio Reports First Quarter 2026 Financial Results

May 7, 2026, 4:05 PM EDT - 5 days ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 30, 2026, 4:43 PM EDT - 12 days ago

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

Apr 21, 2026, 4:05 PM EDT - 21 days ago

TELA Bio to Announce First Quarter 2026 Financial Results

2026-03-27T09:45:34.000Z - 6 weeks ago

Tela Bio price target lowered to $3 from $5 at Citizens

2026-03-25T12:46:38.000Z - 7 weeks ago

Tela Bio price target lowered to $2 from $3 at Lake Street

2026-03-25T10:47:07.000Z - 7 weeks ago

Tela Bio price target lowered to $2 from $4 at Canaccord

2026-03-25T10:45:14.000Z - 7 weeks ago

Tela Bio price target lowered to $1 from $1.25 at Piper Sandler

Mar 24, 2026, 4:30 PM EDT - 7 weeks ago

TELA Bio Earnings Call Transcript: Q4 2025

2026-03-24T20:18:38.000Z - 7 weeks ago

Tela Bio reports Q4 EPS (17c), consensus (18c)

2026-03-24T20:18:24.000Z - 7 weeks ago

Tela Bio sees Q1 revenue $18.5M, consensus $21.27M

Mar 24, 2026, 4:05 PM EDT - 7 weeks ago

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026, 4:05 PM EDT - 2 months ago

TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results

2025-12-12T12:15:29.000Z - 5 months ago

Tela Bio files to sell 2M shares of common stock for holders

Dec 3, 2025, 2:30 PM EST - 5 months ago

TELA Bio Transcript: Piper Sandler 37th Annual Healthcare Conference

2025-12-01T13:45:43.000Z - 5 months ago

Tela Bio price target lowered to $3 from $6 at Lake Street

Nov 19, 2025, 8:30 AM EST - 6 months ago

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

2025-11-18T11:15:46.000Z - 6 months ago

Tela Bio price target lowered to $4 from $7 at Canaccord

2025-11-14T11:51:53.000Z - 6 months ago

Tela Bio price target lowered to $1.25 from $2 at Piper Sandler

2025-11-14T10:55:56.000Z - 6 months ago

Tela Bio price target lowered to $5 from $7 at Citizens JMP

Nov 13, 2025, 4:30 PM EST - 6 months ago

TELA Bio Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:21 PM EST - 6 months ago

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

2025-11-13T21:17:42.000Z - 6 months ago

Tela Bio reports Q3 EPS (19c), consensus (20c)

2025-11-13T21:17:31.000Z - 6 months ago

Tela Bio sees FY25 revenue up at least 16%

Nov 13, 2025, 4:01 PM EST - 6 months ago

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

Oct 9, 2025, 4:05 PM EDT - 7 months ago

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

Aug 13, 2025, 10:00 AM EDT - 9 months ago

TELA Bio Transcript: Canaccord Genuity’s 45th Annual Growth Conference

2025-08-11T20:30:41.000Z - 9 months ago

Tela Bio reports Q2 EPS (22c), consensus (19c)

2025-08-11T20:30:35.000Z - 9 months ago

Tela Bio backs FY25 revenue view $85M-$88M, consensus $86.05M

Aug 11, 2025, 4:30 PM EDT - 9 months ago

TELA Bio Earnings Call Transcript: Q2 2025

Aug 11, 2025, 4:03 PM EDT - 9 months ago

TELA Bio Reports Second Quarter 2025 Financial Results

Jul 23, 2025, 4:03 PM EDT - 10 months ago

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 21, 2025, 4:03 PM EDT - 10 months ago

TELA Bio to Announce Second Quarter 2025 Financial Results

Jun 6, 2025, 4:05 PM EDT - 1 year ago

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 5, 2025, 11:05 AM EDT - 1 year ago

TELA Bio Transcript: Jefferies Global Healthcare Conference 2025

2025-06-03T20:50:13.000Z - 1 year ago

Tela Bio announces European launch of OviTex Inguinal Reinforced Tissue Matrix

Jun 3, 2025, 4:05 PM EDT - 1 year ago

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

2025-06-02T12:40:54.000Z - 1 year ago

Tela Bio appoints Jeffrey Blizard as president, effective immediately

JNJ

Jun 2, 2025, 8:30 AM EDT - 1 year ago

TELA Bio Appoints Jeffrey Blizard as President

May 22, 2025, 4:05 PM EDT - 1 year ago

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

TELA Bio Earnings Call Transcript: Q1 2025

Apr 17, 2025, 4:05 PM EDT - 1 year ago

TELA Bio to Announce First Quarter 2025 Financial Results

2025-03-31T11:16:11.000Z - 1 year ago

Tela Bio announces U.S. launch of larger sizes of OviTex PRS

2025-03-21T13:00:10.000Z - 1 year ago

Tela Bio price target lowered to $6 from $8 at Lake Street, buy on weakness

2025-03-21T10:50:45.000Z - 1 year ago

Tela Bio price target lowered to $7 from $12 at Canaccord

Mar 20, 2025, 4:30 PM EDT - 1 year ago

TELA Bio Earnings Call Transcript: Q4 2024

Mar 20, 2025, 4:05 PM EDT - 1 year ago

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

Dec 3, 2024, 12:00 PM EST - 1 year ago

TELA Bio Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 4:05 PM EST - 1 year ago

TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

TELA Bio Earnings Call Transcript: Q3 2024

Oct 24, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 23, 2024, 8:07 AM EDT - 1 year ago

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Oct 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Oct 17, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Third Quarter 2024 Financial Results

Aug 14, 2024, 10:30 AM EDT - 1 year ago

TELA Bio Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Aug 12, 2024, 4:30 PM EDT - 1 year ago

TELA Bio Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

Jul 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Second Quarter 2024 Financial Results

Jun 4, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

May 20, 2024, 4:03 PM EDT - 2 years ago

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

May 9, 2024, 4:30 PM EDT - 2 years ago

TELA Bio Earnings Call Transcript: Q1 2024

May 9, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Reports First Quarter 2024 Financial Results

Apr 25, 2024, 7:00 AM EDT - 2 years ago

TELA Bio to Announce First Quarter 2024 Financial Results

Apr 15, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

Apr 8, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Mar 21, 2024, 4:30 PM EDT - 2 years ago

TELA Bio Earnings Call Transcript: Q4 2023

Mar 21, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

Mar 21, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Mar 20, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Feb 29, 2024, 7:00 AM EST - 2 years ago

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Dec 5, 2023, 7:00 AM EST - 2 years ago

TELA Bio to Take Part in Connecting the Dots

Nov 30, 2023, 11:00 AM EST - 2 years ago

TELA Bio Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 16, 2023, 7:00 AM EST - 2 years ago

TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference

Nov 9, 2023, 4:30 PM EST - 2 years ago

TELA Bio Earnings Call Transcript: Q3 2023

Nov 9, 2023, 4:05 PM EST - 2 years ago

TELA Bio Reports Third Quarter 2023 Financial Results

Oct 26, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce Third Quarter 2023 Financial Results

Sep 18, 2023, 4:05 PM EDT - 2 years ago

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

Aug 16, 2023, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

Aug 9, 2023, 4:30 PM EDT - 2 years ago

TELA Bio Earnings Call Transcript: Q2 2023

Aug 9, 2023, 4:03 PM EDT - 2 years ago

TELA Bio Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

Jun 15, 2023, 7:00 AM EDT - 3 years ago

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

May 25, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Participate in the Jefferies Global Healthcare Conference

May 19, 2023, 7:00 AM EDT - 3 years ago

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

May 11, 2023, 4:30 PM EDT - 3 years ago

TELA Bio Earnings Call Transcript: Q1 2023

May 11, 2023, 4:02 PM EDT - 3 years ago

TELA Bio Reports First Quarter 2023 Financial Results

May 9, 2023, 7:00 AM EDT - 3 years ago

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

EarningsInsider May. 12 at 10:08 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-tela-bio-inc-stock/ $TELA TELA Bio Earnings Transcript

0 · Reply

StocktwitsEarnings May. 12 at 8:16 PM

0 · Reply

Dr_Monkeybreath May. 6 at 4:11 PM

$TELA back under .70 please. 🥺

0 · Reply

StockScanners May. 5 at 5:32 AM

$TELA reached 1.17

0 · Reply

InvestingSpaceman May. 4 at 8:00 PM

$TELA $CUE $XRX $ESPR 5 day

0 · Reply

ja1234567 May. 4 at 7:10 PM

$TELA I agree with mimedx maybe buying them. Mimedx is moving more into surgical where Telabio lives. This would make them a portfolio surgical company.

0 · Reply

rombrento May. 4 at 6:28 PM

$TELA

0 · Reply

GlobalInsights May. 4 at 5:58 PM

$TELA Took an opening position of 10k shares today. Their new sales force strategy seems to have potential for accelerating growth. Plus seems like a potential buy out target by MDXG.

0 · Reply

Dr_Monkeybreath May. 4 at 1:58 PM

$TELA still hold some free ones. this could spike above $1. 😶‍🌫️

0 · Reply

StockScanners May. 2 at 4:05 PM

$TELA keep watch if this holds above .82

0 · Reply

ja1234567 May. 1 at 8:39 PM

$TELA I’m glad they are up but Capper as the new Chairman of the board ? He has been mismanaging mimedx for several years now and that’s not hard to see.

0 · Reply

Dr_Monkeybreath May. 1 at 4:55 PM

using $TELA 💰 to buy more $GOCO 👍

0 · Reply

Dr_Monkeybreath May. 1 at 4:45 PM

$TELA

0 · Reply

prismmarketview May. 1 at 4:28 PM

PRISM Mid-Day Movers: Global Health and MedTech are Today’s Leaders. Esperion Therapeutics, Inc. (NASDAQ: $ESPR) is surging midday, with shares trading at $3.1101, up 55.51% Shares of TELA Bio, Inc. (NASDAQ: $TELA ) are breaking out midday, with the stock up 25.26% to $1.0958 Other Notable Movers: Everspin Tech. ($MRAM ) up 18% Waldencast plc ($WALD ) up 11% HUB Security ($HUBC ) down -36%

0 · Reply

PLATINUM_TRADES May. 1 at 3:09 PM

$TELA Shhhhh no one is here while this thing has popped nicely for good money 🫰

0 · Reply

PLATINUM_TRADES Apr. 30 at 6:30 PM

$TELA It did the job.. Overnight swing winner 🥇 🥇

0 · Reply

KylaGPS10x Apr. 30 at 5:19 PM

$TELA I sold my .57 to .90 decent trade q1 doesn’t look good so I decided to take profits

0 · Reply

PLATINUM_TRADES Apr. 29 at 7:50 PM

$TELA There we go....i got more alerts coming 🚨🚨

1 · Reply

PLATINUM_TRADES Apr. 29 at 7:05 PM

$TELA I told u..👇👇 Another overnight swing winner. $.84 to break for more 🚨 🚨

0 · Reply

PLATINUM_TRADES Apr. 29 at 3:37 PM

$TELA No reason this can't break $.80... None imo🌞🌞🌞🌞

0 · Reply

nextrated Apr. 28 at 3:24 PM

$TELA needs volume

0 · Reply

RichMitch Apr. 28 at 10:37 AM

$AUUD ... 🔥 Give these "Bears" something to eat 😂 $QQQ $TELA $MSFT $NVDA

0 · Reply

Market Cap	43.43M
Revenue (ttm)	80.28M
Net Income (ttm)	-38.83M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48.37%
Debt to Equity Ratio	8.82

Volume	319,100
Avg Vol	203,364
Day's Range	N/A - N/A
Shares Out	44.77M
Stochastic %K	44%
Beta	1.30
Analysts	Strong Sell
Price Target	$2.25